R H Kukuruzovic1, D R Brewster. 1. Northern Territory Clinical School, Flinders University and Paediatric Department, Royal Darwin Hospital, Australia.
Abstract
OBJECTIVE: To compare three low-lactose milk formulas differing in osmolality and degree of protein hydrolysis in the treatment of diarrhoea and malnutrition in subjects with high rates of lactose intolerance, osmotic diarrhoea and a tropical/environmental enteropathy. METHODS: A randomized double-blind trial of 180 Aboriginal children under 3 years of age admitted with acute diarrhoea and/or malnutrition was carried out. The intervention milk formulas were: (i) De-Lact, a low-osmolality lactose-free formula; (ii) O-Lac, a lactose-free formula; and (iii) Alfaré, a partially hydrolysed formula. Outcome measures were diarrhoeal severity, weight gain, formula palatability and changes in intestinal permeability (L/R ratios). RESULTS: The duration of diarrhoea in days (mean; 95% confidence interval) was significantly longer on Alfaré (8.5; 7.0-10.0) compared to De-Lact (6.1; 5.0-7.2) and O-Lac (6.9; 5.6-8.1; P = 0.04). There were no differences in mean intake between formulas, but palatability of Alfaré was significantly worse (P < 0.01) than the other formulas. Over the trial 5 days, improvement in L/R ratios was significantly greater (P = 0.05) for De-Lact (18.6; 10.6-26.6) than for Alfaré (8.5; 2.1-14.9). Weight gain was not significantly different between the three formulas, except in a malnourished subgroup who had better weight gain on De-Lact (P = 0.05). CONCLUSIONS: In these Aboriginal children with diarrhoea and growth failure, a low osmolality milk was associated with better outcomes and a partially hydrolysed formula with less improvement in mucosal recovery, suggesting that cow's milk protein intolerance is not contributing to greater diarrhoeal severity or enteropathy in Aboriginal children.
RCT Entities:
OBJECTIVE: To compare three low-lactosemilk formulas differing in osmolality and degree of protein hydrolysis in the treatment of diarrhoea and malnutrition in subjects with high rates of lactose intolerance, osmotic diarrhoea and a tropical/environmental enteropathy. METHODS: A randomized double-blind trial of 180 Aboriginal children under 3 years of age admitted with acute diarrhoea and/or malnutrition was carried out. The intervention milk formulas were: (i) De-Lact, a low-osmolality lactose-free formula; (ii) O-Lac, a lactose-free formula; and (iii) Alfaré, a partially hydrolysed formula. Outcome measures were diarrhoeal severity, weight gain, formula palatability and changes in intestinal permeability (L/R ratios). RESULTS: The duration of diarrhoea in days (mean; 95% confidence interval) was significantly longer on Alfaré (8.5; 7.0-10.0) compared to De-Lact (6.1; 5.0-7.2) and O-Lac (6.9; 5.6-8.1; P = 0.04). There were no differences in mean intake between formulas, but palatability of Alfaré was significantly worse (P < 0.01) than the other formulas. Over the trial 5 days, improvement in L/R ratios was significantly greater (P = 0.05) for De-Lact (18.6; 10.6-26.6) than for Alfaré (8.5; 2.1-14.9). Weight gain was not significantly different between the three formulas, except in a malnourished subgroup who had better weight gain on De-Lact (P = 0.05). CONCLUSIONS: In these Aboriginal children with diarrhoea and growth failure, a low osmolality milk was associated with better outcomes and a partially hydrolysed formula with less improvement in mucosal recovery, suggesting that cow's milk protein intolerance is not contributing to greater diarrhoeal severity or enteropathy in Aboriginal children.
Authors: Alison Talbert; Nahashon Thuo; Japhet Karisa; Charles Chesaro; Eric Ohuma; James Ignas; James A Berkley; Christopher Toromo; Sarah Atkinson; Kathryn Maitland Journal: PLoS One Date: 2012-06-04 Impact factor: 3.240
Authors: Robert H J Bandsma; Wieger Voskuijl; Emmanuel Chimwezi; Greg Fegan; André Briend; Johnstone Thitiri; Moses Ngari; Laura Mwalekwa; Victor Bandika; Rehema Ali; Fauzat Hamid; Betty Owor; Neema Mturi; Isabel Potani; Benjamin Allubha; Anneke C Muller Kobold; Rosalie H Bartels; Christian J Versloot; Marjon Feenstra; Deborah A van den Brink; Patrick F van Rheenen; Marko Kerac; Celine Bourdon; James A Berkley Journal: PLoS Med Date: 2019-02-26 Impact factor: 11.069
Authors: Matilda A Kvissberg; Prasad S Dalvi; Marko Kerac; Wieger Voskuijl; James A Berkley; Marion G Priebe; Robert H J Bandsma Journal: Nutr Rev Date: 2015-11-17 Impact factor: 7.110
Authors: Kevin Walsh; Nuala Calder; Peter Olupot-Olupot; Tonny Ssenyondo; William Okiror; Charles Bernard Okalebo; Rita Muhindo; Ayub Mpoya; Elaine Holmes; Julian Marchesi; Gael Delamare de la Villenaise de Chenevarin; Gary Frost; Kathryn Maitland Journal: Wellcome Open Res Date: 2018-08-02